Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Molecular biology. Neutralizing toxic RNA.

× No keyword cloud information.

7 in total

1. Most expression and splicing changes in myotonic dystrophy type 1 and type 2 skeletal muscle are shared with other muscular dystrophies.

Authors: Linda L Bachinski; Keith A Baggerly; Valerie L Neubauer; Tamara J Nixon; Olayinka Raheem; Mario Sirito; Anna K Unruh; Jiexin Zhang; Lalitha Nagarajan; Lubov T Timchenko; Guillaume Bassez; Bruno Eymard; Josep Gamez; Tetsuo Ashizawa; Jerry R Mendell; Bjarne Udd; Ralf Krahe
Journal: Neuromuscul Disord Date: 2013-11-15 Impact factor: 4.296

2. Aberrant RNA homeostasis in amyotrophic lateral sclerosis: potential for new therapeutic targets?

Authors: Christopher J Donnelly; Jonathan C Grima; Rita Sattler
Journal: Neurodegener Dis Manag Date: 2014

Review 3. Antisense oligonucleotides: rising stars in eliminating RNA toxicity in myotonic dystrophy.

Authors: Zhihua Gao; Thomas A Cooper
Journal: Hum Gene Ther Date: 2013-01-30 Impact factor: 5.695

4. HTS-Compatible Patient-Derived Cell-Based Assay to Identify Small Molecule Modulators of Aberrant Splicing in Myotonic Dystrophy Type 1.

Authors: Debra A O'Leary; Leonardo Vargas; Orzala Sharif; Michael E Garcia; Yury J Sigal; Siu-Kei Chow; Christian Schmedt; Jeremy S Caldwell; Achim Brinker; Ingo H Engels
Journal: Curr Chem Genomics Date: 2010-03-19

5. Design of a "Mini" Nucleic Acid Probe for Cooperative Binding of an RNA-Repeated Transcript Associated with Myotonic Dystrophy Type 1.

Authors: Wei-Che Hsieh; Raman Bahal; Shivaji A Thadke; Kirti Bhatt; Krzysztof Sobczak; Charles Thornton; Danith H Ly
Journal: Biochemistry Date: 2018-01-19 Impact factor: 3.162

Review 6. Targeting RNA to treat neuromuscular disease.

Authors: Francesco Muntoni; Matthew J A Wood
Journal: Nat Rev Drug Discov Date: 2011-08-01 Impact factor: 84.694

7. DMPK is a New Candidate Mediator of Tumor Suppressor p53-Dependent Cell Death.

Authors: Katsuhiko Itoh; Takahiro Ebata; Hiroaki Hirata; Takeru Torii; Wataru Sugimoto; Keigo Onodera; Wataru Nakajima; Ikuno Uehara; Daisuke Okuzaki; Shota Yamauchi; Yemima Budirahardja; Takahito Nishikata; Nobuyuki Tanaka; Keiko Kawauchi
Journal: Molecules Date: 2019-09-01 Impact factor: 4.411

7 in total